FDA
-
-
-
-
-
-
-
Genmab Achieves USD 50 Million Sales Milestone in DARZALEX® (daratumumab) Collaboration with Janssen
-
-
-
-
-
-
-
Genmab Announces Financial Results for the First Half of 2017
-
-
-
-
-
-
-
Phase II Study of Daratumumab in Non-Hodgkin’s Lymphoma Will Not Proceed to Stage 2 of Trial
-
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

